These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31463594)

  • 1. Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review.
    Anzola LK; Glaudemans AWJM; Dierckx RAJO; Martinez FA; Moreno S; Signore A
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2496-2513. PubMed ID: 31463594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
    Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
    Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
    Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy in thoracic diseases.
    Ameri P; Gatto F; Arvigo M; Villa G; Resmini E; Minuto F; Murialdo G; Ferone D
    J Endocrinol Invest; 2007 Nov; 30(10):889-902. PubMed ID: 18075294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data.
    Talbot JN; Kerrou K; Missoum F; Grahek D; Aide N; Lumbroso J; Montravers F
    Mol Imaging Biol; 2005; 7(4):257-61. PubMed ID: 16082495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
    Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities.
    Charrier N; Deveze A; Fakhry N; Sebag F; Morange I; Gaborit B; Barlier A; Carmona E; De Micco C; Garcia S; Mancini J; Palazzo FF; Lavieille JP; Zanaret M; Henry JF; Mundler O; Taïeb D
    Clin Endocrinol (Oxf); 2011 Jan; 74(1):21-9. PubMed ID: 21039729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
    Anzola LK; Galli F; Dierckx RA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):197-213. PubMed ID: 25669765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis.
    Geijer H; Breimer LH
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1770-80. PubMed ID: 23873003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
    Pacilio M; Lauri C; Prosperi D; Petitti A; Signore A
    Semin Nucl Med; 2018 May; 48(3):261-276. PubMed ID: 29626943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.
    Ruf J; Steffen I; Mehl S; Rosner C; Denecke T; Pape UF; Plotkin M; Amthauer H
    Nucl Med Commun; 2007 Oct; 28(10):782-8. PubMed ID: 17728608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    Montravers F; Grahek D; Kerrou K; Ruszniewski P; de Beco V; Aide N; Gutman F; Grangé JD; Lotz JP; Talbot JN
    J Nucl Med; 2006 Sep; 47(9):1455-62. PubMed ID: 16954553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
    Schillaci O
    J Nucl Med; 2007 Apr; 48(4):498-500. PubMed ID: 17401084
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in PET to assess pulmonary inflammation: A systematic review.
    Vass L; Fisk M; Lee S; Wilson FJ; Cheriyan J; Wilkinson I
    Eur J Radiol; 2020 Sep; 130():109182. PubMed ID: 32702614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.
    Ćorović A; Wall C; Nus M; Gopalan D; Huang Y; Imaz M; Zulcinski M; Peverelli M; Uryga A; Lambert J; Bressan D; Maughan RT; Pericleous C; Dubash S; Jordan N; Jayne DR; Hoole SP; Calvert PA; Dean AF; Rassl D; Barwick T; Iles M; Frontini M; Hannon G; Manavaki R; Fryer TD; Aloj L; Graves MJ; Gilbert FJ; Dweck MR; Newby DE; Fayad ZA; Reynolds G; Morgan AW; Aboagye EO; Davenport AP; Jørgensen HF; Mallat Z; Bennett MR; Peters JE; Rudd JHF; Mason JC; Tarkin JM
    J Am Coll Cardiol; 2023 Jan; 81(4):336-354. PubMed ID: 36697134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.